[3] Ipamorelin was originally developed by Novo Nordisk, and was investigated in phase II clinical trials by Helsinn Therapeutics for the treatment of postoperative ileus, but was discontinued due to lack of efficacy
Yes, there is a new, non-injectable version of oral semaglutide by Wegovy that came on the market in January 2026
The rush to prescribe the trendy drugs, even in a shaky economy, shows how lucrative these companies think the programs could be and for some players, it could be a chance to turn their businesses around
It also helps control your blood sugar, reducing the risk of hunger-inducing glucose spikes
We keep a close eye on how patients react to treatment and adjust the dose as needed
Position on lipotropic injections: The NHS does not endorse lipotropic injections for weight management or metabolic enhancement